Whole-exome analysis reveals novel somatic genomic alterations associated with outcome in immunochemotherapy-treated diffuse large B-cell lymphoma

Lack of remission or early relapse remains a major clinical issue in diffuse large B-cell lymphoma (DLBCL), with 30% of patients failing standard of care. Although clinical factors and molecular signatures can partially predict DLBCL outcome, additional information is needed to identify high-risk pa...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Blood Cancer J
Auteurs principaux: Novak, A J, Asmann, Y W, Maurer, M J, Wang, C, Slager, S L, Hodge, L S, Manske, M, Price-Troska, T, Yang, Z-Z, Zimmermann, M T, Nowakowski, G S, Ansell, S M, Witzig, T E, McPhail, E, Ketterling, R, Feldman, A L, Dogan, A, Link, B K, Habermann, T M, Cerhan, J R
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2015
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4558593/
https://ncbi.nlm.nih.gov/pubmed/26314988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2015.69
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires